Table 1 Demographic data at baseline
From: A randomized controlled efficacy study of the Medido medication dispenser in Parkinson’s disease
Demographic data | Medido (n = 36) | Control (n = 51) | Sign. Difference between groups | |
|---|---|---|---|---|
Gender (n (%)) | Male | 24 (67) | 35 (69) | p = 0.847 |
Age (mean (SD)) | Years | 69 (7) | 68 (11) | p = 0.482 |
Hoehn & Yahr (n (%)) | ≤ 2.5 | 18 (50) | 30 (59) | p = 0.415 |
> 2.5 | 18 (50) | 21 (41) | ||
Disease duration (n (%)) | 0–5 years | 16 (44) | 17 (33) | p = 0.159 |
5–10 years | 9 (15) | 23 (45) | ||
≥ 10 years | 11 (31) | 11 (22) | ||
Caregiver available (n (%)) | Yes | 25 (69%) | 33 (65%) | p = 0.644 |
Levodopa Equivalent Dose (mean (SD)) | Baseline ΔBL-6 months | 851 (415) | 799 (331) | p = 0.546 |
69 (98) | 68 (136) | p = 0.947 |